| ABEONA THERAPEUTICS |
| USA |
| Gesundheit |
| US00289Y2063 / A3DMHM |
| PCJ (Frankfurt) / ABEO (NASDAQ) |
| FRA:PCJ, ETR:PCJ, PCJ:GR, NASDAQ:ABEO |
| - |
| https://www.abeonatherape.. |
|
Abeona Therapeutics Inc. is a biopharmaceutical company focused on developing gene and cell therapies for rare genetic diseases. The company's primary objective is to harness the transformative power ..
>Volltext.. |
| 236.5 Mio. EUR |
| 79 Mio. EUR |
| 0.34 Mio. EUR |
| -68.97 Mio. EUR |
| 71.02 Mio. EUR |
| 1.32 EUR |
| 20.79 Mio. EUR |
| 71.78 Mio. EUR |
| -64.63 Mio. EUR |
| 9.35 |
| - |
| - |
| - |
| - |
| - |
| ABEONA THERAPEUTICS, ABEONA THERAPEUTIC |
| 04.03.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|